Permitted Assignment by Licensee. Subject to Section 16.3, Licensee may assign this Agreement as part of a sale, regardless of whether such a sale occurs through an asset sale, stock sale, merger or other combination, or any other transfer of: (A) Licensee's entire business; or (B) that part of Licensee’s business that exercises all rights granted under this Agreement.
Appears in 2 contracts
Samples: Exclusive (Equity) Agreement, Exclusive (Equity) Agreement
Permitted Assignment by Licensee. Subject to Section 16.3the conditions described below, Licensee may assign this Agreement as part of a sale, regardless of whether such a sale occurs through an asset sale, stock sale, merger or other combination, or any other transfer of:
(A) : Licensee's ’s entire business; or
(B) or that part of Licensee’s business that exercises all rights granted under this Agreement.”
Appears in 2 contracts
Samples: Exclusive License Agreement (Histogenics Corp), Exclusive License Agreement (Histogenics Corp)
Permitted Assignment by Licensee. Subject to Section 16.313.3, Licensee may assign this Agreement Agreement: (a) as part of a salesale or change of control, regardless of whether such a sale or change of control occurs through an asset sale, stock sale, merger or other combination, or any other transfer of:
(A) of Licensee's ’s entire business; or
(B) business or that part of Licensee’s business that exercises all rights granted under this Agreement.; or
Appears in 2 contracts
Samples: Asset Purchase Agreement (Eiger BioPharmaceuticals, Inc.), Asset Purchase Agreement (Celladon Corp)
Permitted Assignment by Licensee. Subject to Section 16.3, Licensee may assign this Agreement as part of a sale, regardless of whether such a sale occurs through an asset sale, stock equity sale, merger or other combination, or any other transfer of:
(A) Licensee's ’s entire business; or
(B) that the part of Licensee’s business that exercises all rights granted under this Agreement.
Appears in 1 contract
Samples: Technology Transfer Agreement (Qualigen Therapeutics, Inc.)